IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, giving promising breakthroughs across several healthcare and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, additional trusted alternative for therapeutic use, s